PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Entries stay only in this open page and are not saved or sent.
Published record starting point
- Record display name
- JENTADUETO XR
- Generic name / active ingredient
- linagliptin and metformin hydrochloride extended-release tablets
- Dosage-form class
- Linagliptin/metformin hydrochloride film-coated extended-release tablets: 2.5 mg/1,000 mg and 5 mg/1,000 mg (current U.S. public label)
- Route
- Oral
- Record reviewed
- 2026-08-30
Copy from the pack in hand
Source-linked reading points
- For example, 2.5 mg/1,000 mg means 2.5 mg linagliptin and 1,000 mg metformin HCl per tablet. It is not a comparable 1,002.5 mg strength or two times of day.
- The label requires swallowing whole and says not to split, crush, dissolve or chew. The site does not use clinician-facing regimens in the label to choose an individual's frequency, tablet count or transition method.
- The boxed warning covers metformin-associated lactic acidosis. Kidney function, age 65 or older, iodinated contrast, surgery, hypoxic states, excessive alcohol and hepatic impairment are label-listed priority review boundaries.
- Severe weakness, breathing difficulty, persistent vomiting, marked altered awareness, severe abdominal pain or another acute serious concern requires local emergency help with every medicine pack. Do not wait for a webpage to decide interruption or make-up use.
Reviewed presentation examples — compare every field
- 2.5 mg linagliptin + 1,000 mg metformin HCl per tablet; 60-tablet bottleNDC 0597-0270-73
- 5 mg linagliptin + 1,000 mg metformin HCl per tablet; 30-tablet bottleNDC 0597-0275-33